Lushen Li

1.4k total citations
47 papers, 981 citations indexed

About

Lushen Li is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lushen Li has authored 47 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Oncology. Recurrent topics in Lushen Li's work include Immunotherapy and Immune Responses (8 papers), Gut microbiota and health (6 papers) and Immune Cell Function and Interaction (6 papers). Lushen Li is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Gut microbiota and health (6 papers) and Immune Cell Function and Interaction (6 papers). Lushen Li collaborates with scholars based in United States, China and Bangladesh. Lushen Li's co-authors include Jonathan S. Bromberg, Vikas Saxena, Reza Abdi, Jin Cai, Wenji Piao, Junqing Chen, Yanbao Xiong, Christopher M. Jewell, Ning Gu and Christina Paluskievicz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Lushen Li

45 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lushen Li United States 20 354 284 176 116 101 47 981
Anna Radzikowska Poland 11 593 1.7× 225 0.8× 162 0.9× 103 0.9× 104 1.0× 24 1.1k
Akira Takeda Japan 17 418 1.2× 261 0.9× 270 1.5× 116 1.0× 52 0.5× 45 983
Weiwei An China 21 694 2.0× 150 0.5× 66 0.4× 158 1.4× 188 1.9× 31 1.2k
Hongyan Cui China 20 521 1.5× 157 0.6× 119 0.7× 72 0.6× 233 2.3× 55 1.1k
Haoran Xu China 21 612 1.7× 130 0.5× 137 0.8× 57 0.5× 123 1.2× 78 1.3k
Yumiko Wada Japan 16 695 2.0× 223 0.8× 220 1.3× 83 0.7× 66 0.7× 59 1.3k
Xianzhou Song United States 15 521 1.5× 175 0.6× 193 1.1× 46 0.4× 119 1.2× 18 1.0k
Kelly Fitzgerald United States 8 399 1.1× 370 1.3× 78 0.4× 41 0.4× 51 0.5× 22 973
Xinyuan Zhao China 17 666 1.9× 240 0.8× 85 0.5× 118 1.0× 65 0.6× 28 1.0k
Rob Ruijtenbeek Netherlands 21 854 2.4× 151 0.5× 219 1.2× 215 1.9× 54 0.5× 64 1.2k

Countries citing papers authored by Lushen Li

Since Specialization
Citations

This map shows the geographic impact of Lushen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lushen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lushen Li more than expected).

Fields of papers citing papers by Lushen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lushen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lushen Li. The network helps show where Lushen Li may publish in the future.

Co-authorship network of co-authors of Lushen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lushen Li. A scholar is included among the top collaborators of Lushen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lushen Li. Lushen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Long, Samuel J. Gavzy, Yang Song, et al.. (2025). Immunosuppressants rewire the gut microbiome-alloimmune axis through time-dependent and tissue-specific mechanisms. Cell Communication and Signaling. 23(1). 506–506.
2.
Wu, Long, Tao Zhang, Danielle D. Kish, et al.. (2025). Lymph Node Scarring Prevents Allograft Survival by Altering Fibroblastic Reticular Cells. American Journal of Transplantation. 25(8). S820–S820. 1 indexed citations
3.
Guo, Yizhan, Dongge Li, Anirban Banerjee, et al.. (2024). Eosinophils restrain humoral alloimmunity after lung transplantation. JCI Insight. 9(3). 7 indexed citations
4.
Li, Lushen, Long Wu, Jing Zhao, et al.. (2023). FRC transplantation restores lymph node conduit defects in laminin α4–deficient mice. JCI Insight. 8(8). 7 indexed citations
5.
Piao, Wenji, Lushen Li, Vikas Saxena, et al.. (2022). PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nature Communications. 13(1). 2176–2176. 47 indexed citations
6.
Saxena, Vikas, Wenji Piao, Lushen Li, et al.. (2022). Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Reports. 39(3). 110727–110727. 16 indexed citations
7.
Li, Lushen, Jing Wu, Reza Abdi, Christopher M. Jewell, & Jonathan S. Bromberg. (2021). Lymph node fibroblastic reticular cells steer immune responses. Trends in Immunology. 42(8). 723–734. 60 indexed citations
8.
Li, Lushen, Tianshu Zhang, Yanbao Xiong, et al.. (2020). The lymph node stromal laminin α5 shapes alloimmunity. Journal of Clinical Investigation. 130(5). 2602–2619. 30 indexed citations
9.
Lee, Young Shin, Tianshu Zhang, Vikas Saxena, et al.. (2020). Myeloid-derived suppressor cells expand after transplantation and their augmentation increases graft survival. American Journal of Transplantation. 20(9). 2343–2355. 18 indexed citations
10.
Xiong, Yanbao, Wenji Piao, C. Colin Brinkman, et al.. (2019). CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration. Science Immunology. 4(33). 73 indexed citations
11.
Bromberg, Jonathan S., Lauren Hittle, Yanbao Xiong, et al.. (2018). Gut microbiota–dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes. JCI Insight. 3(19). 54 indexed citations
12.
Piao, Wenji, Yanbao Xiong, Konrad S. Famulski, et al.. (2018). Regulation of T cell afferent lymphatic migration by targeting LTβR-mediated non-classical NFκB signaling. Nature Communications. 9(1). 3020–3020. 34 indexed citations
13.
Li, Lushen, et al.. (2017). Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. Journal of Cell Science. 130(8). 1475–1485. 10 indexed citations
14.
Cao, Cheng, et al.. (2016). MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. Leukemia. 30(6). 1327–1334. 17 indexed citations
15.
Li, Lushen, et al.. (2016). The SH3 domain distinguishes the role of I-BAR proteins IRTKS and MIM in chemotactic response to serum. Biochemical and Biophysical Research Communications. 479(4). 787–792. 9 indexed citations
16.
Zhou, Gaoxin, Lushen Li, Jing Xing, et al.. (2016). Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery. Colloids and Surfaces B Biointerfaces. 148. 518–525. 32 indexed citations
17.
Cai, Jin, Hongtao Wei, Kwon Ho Hong, et al.. (2015). Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors. European Journal of Medicinal Chemistry. 96. 1–13. 44 indexed citations
18.
Cai, Jin, Ligang Liu, Kwon Ho Hong, et al.. (2015). Discovery of phenoxybutanoic acid derivatives as potent endothelin antagonists with antihypertensive activity. Bioorganic & Medicinal Chemistry. 23(4). 657–667. 19 indexed citations
19.
Chen, Lukui, Rong Qiu, & Lushen Li. (2014). The Role of Nanotechnology in Induced Pluripotent and Embryonic Stem Cells Research. Journal of Biomedical Nanotechnology. 10(12). 3431–3461. 3 indexed citations
20.
Gu, Ning, et al.. (2012). The Wittig–Horner reaction for the synthesis of neratinib. Research on Chemical Intermediates. 39(7). 3105–3110. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026